Purchase of angio-proteomie primary human endothelial cells of varying tissue origins (brand-name only). This is a covid-19 action.

Ended Purchase Order Awarded

Contract number
75N95022P00609
Awardee
Awarding agency
Obligated
$56,460

Award facts

Opportunity
Contract value 100% obligated
$56,460.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Boston, MA 02215, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75N95022P00609?

75N95022P00609 was awarded to Angio-Proteomie LLC by National Institute on Drug Abuse (National Institutes of Health) on September 9, 2022.

How much is contract 75N95022P00609 worth?

The government has obligated $56,460 on 75N95022P00609.

Which agency awarded contract 75N95022P00609?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00609, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95022P00609 competed?

The extent of competition for 75N95022P00609 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login